AC
Casini, Alessandro
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Management of Young and Ageing Women with Afibrinogenemia and Hypofibrinogenemia | Hämostaseologie |  | 2025 | 5 | 3 | ||
| How I treat quantitative fibrinogen disorders | Blood |  | 2025 | 34 | 0 | ||
| Women and hereditary bleeding disorders | Hämostaseologie | | 2025 | 46 | 53 | ||
| Gynecologic and obstetric complications in women with congenital fibrinogen disorders: insights from the Prospective Rare Bleeding Disorders Database | Research and practice in thrombosis and haemostasis | | 2025 | 5 | 6 | ||
| Enhancing hemostasis potency in hemophilia with a small interfering ribonucleic acid targeting protein S | Journal of thrombosis and haemostasis | | 2025 | 4 | 0 | ||
| A novel FGG missense variant associated with fibrinogen storage disease in a large family from Quebec | Haemophilia | | 2024 | 56 | 0 | ||
| Perinatal stroke and hypofibrinogenemia : Is the new missense fibrinogen variant γ p.Gly310Glu the cause of the procoagulant state ? | Thrombosis research | | 2024 | 59 | 0 | ||
| Angiologie et hémostase : ce qui a changé en 2023 | Revue médicale suisse | | 2024 | 92 | 3 | ||
| Diagnostic value of clot formation parameters determined by rotational thromboelastometry in 63 patients with congenital dysfibrinogenemia | Blood coagulation & fibrinolysis | | 2024 | 79 | 49 | ||
| Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database | Blood advances | | 2024 | 102 | 41 | ||
| Management of anticoagulation and factor XIII replacement in a patient with severe factor XIII deficiency and recurrent venous thromboembolic disease: case report and review of literature | Research and practice in thrombosis and haemostasis | | 2024 | 75 | 69 | ||
| Management of pregnancy and delivery in congenital fibrinogen disorders: communication from the ISTH SSC Subcommittee on Factor XIII and Fibrinogen | Journal of thrombosis and haemostasis | | 2024 | 74 | 0 | ||
| Rare bleeding disorders: Advances in management | Haemophilia | | 2024 | 48 | 137 | ||
| Clinical, laboratory, and molecular aspects of congenital fibrinogen disorders | Seminars in thrombosis and hemostasis | | 2024 | 49 | 0 | ||
| How to investigate mild to moderate bleeding disorders and bleeding disorder of unknown cause | International journal of laboratory hematology | | 2024 | 74 | 179 | ||
| Highly thrombogenic phenotype and impaired wound healing in a patient with congenital dysfibrinogenemia : case report | Research and practice in thrombosis and haemostasis | | 2024 | 91 | 38 | ||
| Challenges in the diagnosis and management of patients with rare coagulation disorders in Lebanon and consequences of a social and economic crisis | Haemophilia | | 2024 | 35 | 0 | ||
| 2023 ACR/EULAR antiphospholipid syndrome classification criteria | Annals of the rheumatic diseases | | 2023 | 132 | 198 | ||
| Physiological correction of hereditary mild hypofibrinogenemia during pregnancy | Haemophilia | | 2023 | 194 | 345 | ||
| Addressing some challenges of congenital fibrinogen disorders in 2023 and beyond | Bleeding, thrombosis and vascular biology | | 2023 | 55 | 72 | ||
| Angiologie et hémostase : ce qui a changé en 2022 | Revue médicale suisse | | 2023 | 102 | 48 | ||
| Recommendations for the use of andexanet alfa in the management of bleeding in patients on oral factor Xa inhibitors in Switzerland: Guideline from the Working Party Hemostasis of the Swiss Society of Hematology | Swiss medical weekly | | 2023 | 76 | 54 | ||
| Pharmacodynamics Monitoring of Emicizumab in Patients with Hemophilia A | Thrombosis and haemostasis | | 2023 | 146 | 0 | ||
| 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria | Arthritis & rheumatology | | 2023 | 79 | 0 | ||
| High incidence of intracranial haemorrhage in Egyptian children with congenital afibrinogenaemia | Haemophilia | | 2023 | 49 | 0 | ||
| International council for standardisation in haematology recommendations on fibrinogen assays, thrombin clotting time and related tests in the investigation of bleeding disorders | International journal of laboratory hematology | | 2023 | 75 | 77 | ||
| Coexpression of factor VIII and factor von Willebrand variants in a woman with heavy menstrual bleeding | Blood coagulation & fibrinolysis | | 2023 | 62 | 0 | ||
| Management of rare inherited bleeding disorders: Proposals of the French Reference Centre on Haemophilia and Rare Coagulation Disorders | European journal of haematology | | 2023 | 63 | 77 | ||
| Longitudinal profile of estrogen-related thrombotic biomarkers after cessation of combined hormonal contraceptives | Blood | | 2023 | 103 | 47 | ||
| Obstetrical complications in hereditary fibrinogen disorders: the Fibrinogest Study | Journal of thrombosis and haemostasis | | 2023 | 77 | 0 | ||
| Prothrombotic biomarkers during controlled ovarian stimulation for assisted reproductive technology | Fertility and sterility | | 2023 | 126 | 0 | ||
| Effect of therapeutic anticoagulation on gas exchange in mechanically ventilated COVID-19 patients: A secondary analysis of the COVID-HEP trial | Thrombosis research | | 2023 | 303 | 54 | ||
| Clinicians’ adherence to guidelines for the preoperative management of direct oral anticoagulants in a tertiary hospital: a retrospective study | BMC Anesthesiology | | 2023 | 84 | 65 | ||
| Fifty years of fibrinogen structure and function | Seminars in thrombosis and hemostasis | | 2023 | 109 | 5 | ||
| Hemizygous FGG p.Ala108Gly in a hypofibrinogenemic patient with a heterozygous 14.8 Mb deletion encompassing the entire fibrinogen gene cluster | Haemophilia | | 2022 | 213 | 2 | ||
| Differential impact of tamoxifen and aromatase inhibitors on thrombin generation: the prospective HEMOBREAST cohort | Blood advances | | 2022 | 256 | 252 | ||
| Angiologie-hémostase - Année 2021 : morceaux choisis | Revue médicale suisse | | 2022 | 85 | 55 | ||
| One Hundred Years of Congenital Fibrinogen Disorders | Seminars in thrombosis and hemostasis | | 2022 | 295 | 0 | ||
| Place des anticoagulants oraux directs dans le traitement des thromboses veineuses de localisation inhabituelle | Revue médicale suisse | | 2022 | 118 | 56 | ||
| Impact of fibrinogen infusion on thrombin generation and fibrin clot structure in patients with inherited afibrinogenemia | Thrombosis and haemostasis | | 2022 | 157 | 2 | ||
| Therapeutic anticoagulation to prevent thrombosis, coagulopathy, and mortality in severe COVID-19: The Swiss COVID-HEP randomized clinical trial | Research and practice in thrombosis and haemostasis | | 2022 | 229 | 225 | ||
| A homozygous duplication of the FGG exon 8-intron 8 junction causes congenital afibrinogenemia. Lessons learned from the study of a large consanguineous Turkish family | Haematologica | | 2022 | 315 | 158 | ||
| Saignements d’origine indéterminée : approche diagnostique et thérapeutique | Revue médicale suisse | | 2022 | 68 | 126 | ||
| How I treat dysfibrinogenemia | Blood | | 2021 | 317 | 522 | ||
| Novel missense mutations affecting the structure of the conserved fibrinogen Bβ C-terminal domain cause congenital hypofibrinogenemia | Thrombosis Research | | 2021 | 193 | 106 | ||
| Afibrinogenemia with two compound heterozygous mutations in FGA gene | Haemophilia | | 2021 | 258 | 0 | ||
| Fibrin clot properties to assess the bleeding phenotype in unrelated patients with hypodysfibrinogenemia due to novel fibrinogen mutations | Thrombosis Research | | 2021 | 561 | 4 | ||
| Whole blood thromboelastometry by ROTEM and thrombin generation by genesia according to the genotype and clinical phenotype in congenital fibrinogen disorders | International Journal of Molecular Sciences | | 2021 | 210 | 63 | ||
| Clinical phenotype, fibrinogen supplementation, and health-related quality of life in patients with afibrinogenemia | Blood | | 2021 | 268 | 142 | ||
| Comparison of different activators of coagulation by turbidity analysis of hereditary dysfibrinogenemia and controls | Blood Coagulation and Fibrinolysis | | 2021 | 215 | 0 | ||
| Perioperative management of a severe congenital hypofibrinogenemia with thrombotic phenotype | Thrombosis Research | | 2020 | 340 | 44 | ||
| Identification and expression of a novel heterozygous frameshift mutation in FGA accounting for congenital hypofibrinogenemia in carriers of severe hemophilia A | Thrombosis Research | | 2020 | 256 | 2 | ||
| Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines | Swiss Medical Weekly | | 2020 | 527 | 222 | ||
| Risque thrombotique veineux induit par le SARS-CoV-2 : prévalence, recommandations et perspectives | Revue médicale suisse | | 2020 | 331 | 182 | ||
| From Routine to Research Laboratory: Strategies for the Diagnosis of Congenital Fibrinogen Disorders | Hämostaseologie | | 2020 | 260 | 3 | ||
| Fibrin(ogen) in human disease: both friend and foe | Haematologica | | 2020 | 441 | 288 | ||
| A Unique Case of Acquired Hemophilia A Presenting with Transient Ischemic Attack | Acta Haematologica | | 2020 | 317 | 273 | ||
| Contraception et maladie thromboembolique veineuse | Revue médicale suisse | | 2020 | 252 | 133 | ||
| Suggestions for thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19 | Swiss Medical Weekly | | 2020 | 336 | 754 | ||
| Safety of variceal band ligation in patients with cirrhosis and portal vein thrombosis treated with anticoagulant therapy: A retrospective study | European Journal of Gastroenterology and Hepatology | | 2020 | 399 | 470 | ||
| Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in Switzerland | Swiss Medical Weekly | | 2020 | 591 | 233 | ||
| A novel nonsense mutation in FBG (c.1421G>A;p.Trp474Ter) in the beta chain of fibrinogen causing hypofibrinogenemia with bleeding phenotype | Biomedicines | | 2020 | 261 | 128 | ||
| Molecular characterization of two hypofibrinogenemic patients associated with a novel FGG IVS6+23T>A substitution and a previously reported FGB IVS6-10_16delTTTG deletion | Haemophilia |  | 2020 | 322 | 0 | ||
| Heterogeneity of congenital afibrinogenemia, from epidemiology to clinical consequences and management | Blood Reviews | | 2020 | 250 | 267 | ||
| Management of bleeding events and invasive procedures in patients with haemophilia A without inhibitors treated with emicizumab | Swiss medical weekly | | 2020 | 171 | 67 | ||
| Hepatocellular type II fibrinogen inclusions in a patient with severe COVID-19 and hepatitis | Journal of Hepatology | | 2020 | 388 | 91 | ||
| Congenital structural and functional fibrinogen disorders: a primer for internists | Polskie Archiwum Medycyny Wewnetrznej | | 2019 | 523 | 283 | ||
| Fibrinogen concentrates in hereditary fibrinogen disorders: past, present and future | Haemophilia | | 2019 | 291 | 0 | ||
| Obstetrical and postpartum complications in women with hereditary fibrinogen disorders: a systematic literature review | Haemophilia | | 2019 | 409 | 1 | ||
| Impaired factor XIII activation in patients with congenital afibrinogenemia | Haematologica | | 2019 | 332 | 104 | ||
| A unique factor XIII mutation in southeastern Iran with an unexpectedly high prevalence: khash factor XIII | Seminars in Thrombosis and Hemostasis | | 2019 | 362 | 0 | ||
| The impact of haemophilia on the social status and the health-related quality of life in adult Lebanese persons with haemophilia | Haemophilia | | 2019 | 362 | 0 | ||
| Thrombin generation and fibrin clot structure after vitamin D supplementation | Endocrine Connections | | 2019 | 372 | 155 | ||
| Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report | HemaSphere | | 2019 | 248 | 290 | ||
| Hereditary fibrinogen disorders: toward a tailored management | | 2019 | 332 | 12 | |||
| Antithrombotiques dans le syndrome des anticorps antiphospholipides thrombotique | Revue médicale suisse | | 2018 | 341 | 133 | ||
| Clinical Consequences and Molecular Bases of Low Fibrinogen Levels | International Journal of Molecular Sciences | | 2018 | 572 | 210 | ||
| Heterozygous FGA p.Asp473Ter (fibrinogen Nieuwegein) presenting as antepartum cerebral thrombosis | Thrombosis Research | | 2018 | 459 | 1 | ||
| Mutational epidemiology of congenital fibrinogen disorders | Thrombosis and Haemostasis | | 2018 | 563 | 624 | ||
| Traitements antithrombotiques et anomalies constitutionnelles hémorragipares de l'hémostase | Revue médicale suisse | | 2018 | 352 | 133 | ||
| Acide tranexamique dans la prise en charge de l'hémorragie du postpartum : connaissances actuelles | Revue médicale suisse | | 2018 | 428 | 107 | ||
| A fibrin biofilm covers blood clots and protects from microbial invasion | Journal of Clinical Investigation | | 2018 | 479 | 247 | ||
| Diagnosis and classification of congenital fibrinogen disorders: communication from the SSC of the ISTH | Journal of Thrombosis and Haemostasis | | 2018 | 422 | 28 | ||
| Fibrinogen Mahdia: A congenitally abnormal fibrinogen characterized by defective fibrin polymerization | Haemophilia | | 2017 | 417 | 1 | ||
| Genetics, diagnosis and clinical features of congenital hypodysfibrinogenemia: a systematic literature review and report of a novel mutation | Journal of thrombosis and haemostasis | | 2017 | 591 | 202 | ||
| Thromboses veineuses splanchniques | Revue médicale suisse | | 2017 | 423 | 160 | ||
| A novel fibrinogen mutation: FGA g. 3057 C > T (p. Arg104 > Cys) impairs fibrinogen secretion | BMC Hematology | | 2017 | 443 | 143 | ||
| Protein modelling to understand FGB mutations leading to congenital hypofibrinogenaemia | Haemophilia | | 2017 | 534 | 4 | ||
| Impact of pneumatic tube system transport for the monitoring of heparin therapy | Thrombosis Research | | 2017 | 448 | 0 | ||
| Laboratory and Genetic Investigation of Mutations Accounting for Congenital Fibrinogen Disorders | Seminars in thrombosis and hemostasis | | 2016 | 566 | 0 | ||
| Pregnancy | Trauma Induced Coagulopathy | | 2016 | 420 | 2 | ||
| Diagnostic des anomalies congénitales du fibrinogène | Annales de biologie clinique | | 2016 | 667 | 1 | ||
| Clinical Features and Management of Congenital Fibrinogen Deficiencies | Seminars in thrombosis and hemostasis | | 2016 | 580 | 5 | ||
| Can the phenotype of inherited fibrinogen disorders be predicted? | Haemophilia | | 2016 | 625 | 2 | ||
| Factor concentrates for rare congenital coagulation disorders: where are we now? | Expert opinion on orphan drugs | | 2016 | 438 | 0 | ||
| Management of congenital quantitative fibrinogen disorders: a Delphi consensus | Haemophilia | | 2016 | 519 | 0 | ||
| Risks of venous thromboembolism after cesarean sections: A meta-analysis | Chest | | 2016 | 474 | 0 | ||
| Congenital Disorders of Fibrinogen: Clinical Presentations, Diagnosis and Management | Nonmalignant Hematology Expert Clinical Review : Questions and Answers | | 2016 | 488 | 0 | ||
| Natural history of patients with congenital dysfibrinogenemia | Blood | | 2015 | 714 | 4 | ||
| Successful pregnancy under fibrinogen substitution in a woman with congenital afibrinogenaemia complicated by a postpartum venous thrombosis | Haemophilia | | 2015 | 503 | 0 | ||
| Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management | Journal of thrombosis and haemostasis | | 2015 | 704 | 444 | ||
| Maladies héréditaires du fibrinogène: de la biologie moléculaire à la clinique | | 2015 | 1,100 | 23 | |||
| Fibrin clot structure in patients with congenital dysfibrinogenaemia | Thrombosis research | | 2015 | 532 | 2 | ||
| Hypofibrinogenemia and liver disease: a new case of Aguadilla fibrinogen and review of the literature | Haemophilia | | 2015 | 558 | 5 | ||
| Comparing Two Types of Rabbit ATG prior to Reduced Intensity Conditioning Allogeneic Hematopoietic SCT for Hematologic Malignancies | Bone marrow research | | 2015 | 689 | 310 | ||
| Hémostase. Aspirine: une ou deux fois par jour? | Revue médicale suisse | | 2014 | 564 | 0 | ||
| Validation of the disease risk index for outcome of patients undergoing allogeneic hematopoietic stem cell transplantation after T cell depletion | Biology of blood and marrow transplantation | | 2014 | 586 | 1 | ||
| Fibrinogen geneva II: a new congenitally abnormal fibrinogen alpha chain (Gly17Asp) with a review of similar mutations resulting in abnormal knob A | Blood coagulation & fibrinolysis | | 2014 | 641 | 3 | ||
| FGB mutations leading to congenital quantitative fibrinogen deficiencies: an update and report of four novel mutations | Thrombosis research | | 2014 | 669 | 9 | ||
| Acquired factor XIII deficiency: a therapeutic challenge | Thrombosis and haemostasis | | 2013 | 630 | 0 | ||
| Hémostase : nouveaux anticoagulants oraux : de la théorie à la pratique | Revue médicale suisse | | 2013 | 400 | 0 | ||
| Pulmonary embolism and fatal stroke in a patient with severe factor XI deficiency after bariatric surgery | Blood coagulation & fibrinolysis | | 2013 | 494 | 0 | ||
| Could Factor XIII be a solution for the management of surgical bleeding? | Management and Severe Bleeding | | 2013 | 365 | 0 | ||
| Congenital fibrinogen disorders: an update | Seminars in thrombosis and hemostasis | | 2013 | 725 | 0 | ||
| Thrombotic complications of myeloproliferative neoplasms: risk assessment and risk-guided management | Journal of thrombosis and haemostasis | | 2013 | 667 | 0 | ||
| Thrombophilie : quel bilan en 2012? | La Revue de médecine interne | | 2012 | 487 | 0 | ||
| Recurrent Syncope due to Esophageal Squamous Cell Carcinoma | Case reports in oncology | | 2011 | 667 | 278 |
